Isao Muramatsu
Director/Board Member at Pinecrest Co., Ltd.
Profile
Isao Muramatsu is currently working as a Representative Director at Pinecrest Co., Ltd., Director at s.maX Co., Ltd., and Representative Director at Sun Pharma Japan Ltd.
He previously worked as a Director at GlaxoSmithKline KK, Director at Santen Pharmaceutical Co., Ltd., External Director at Sosei Group Corp., Representative Director, EVP & GM-Pharmaceuticals at Bristol-Myers Squibb KK, President & Representative Director at Smithkline Beecham Seiyaku K.K., and Independent Director at Graphico, Inc. He also worked as Vice President-Sales Department at Pfizer Japan, Inc. from 1984 to 2011.
He completed his undergraduate degree from Keio University.
Isao Muramatsu active positions
| Companies | Position | Start |
|---|---|---|
| Pinecrest Co., Ltd. | Director/Board Member | 2010-11-08 |
s.maX Co., Ltd.
 s.maX Co., Ltd. Medical/Nursing ServicesHealth Services s.maX Co., Ltd. provides health care services. The private company is based in Tokyo, Japan. | Director/Board Member | 2003-05-31 |
Sun Pharma Japan Ltd.
 Sun Pharma Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Sun Pharmaceutical Industries Ltd., Sun Pharma Japan Ltd. is a specialty generic pharmaceutical company based in Tokyo, Japan. The Japanese company remains committed to creating long term value for its shareholders and focuses on performance and producing consistent returns. The Ministry of Corporate Affairs (MCA) notified the IEPF (Uploading of Information Regarding Unpaid and Unclaimed Amounts Lying with Companies) Rules, 2012 (IEPF Rules), which is applicable to the corporation. Information and announcements about this can be found on the company's website. The company has revenues of over US$ 4.5 billion and completed the acquisition of Ranbaxy Laboratories Limited, an international pharmaceutical company, in 2015. | Director/Board Member | 2012-06-30 |
Former positions of Isao Muramatsu
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Director/Board Member | - |
| GRAPHICO, INC. | Director/Board Member | - |
| Smithkline Beecham Seiyaku K.K. | President | - |
Bristol-Myers Squibb KK
 Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan. | Director/Board Member | - |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Director/Board Member | - |
Training of Isao Muramatsu
| Keio University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 3 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| NXERA PHARMA CO., LTD. | Health Technology |
| GRAPHICO, INC. | Consumer Non-Durables |
| Private companies | 7 |
|---|---|
GlaxoSmithKline KK
GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Consumer Non-Durables |
Pfizer Japan, Inc.
Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Commercial Services |
Bristol-Myers Squibb KK
Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan. | Health Technology |
| Smithkline Beecham Seiyaku K.K. | |
| Pinecrest Co., Ltd. | |
s.maX Co., Ltd.
s.maX Co., Ltd. Medical/Nursing ServicesHealth Services s.maX Co., Ltd. provides health care services. The private company is based in Tokyo, Japan. | Health Services |
Sun Pharma Japan Ltd.
Sun Pharma Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Sun Pharmaceutical Industries Ltd., Sun Pharma Japan Ltd. is a specialty generic pharmaceutical company based in Tokyo, Japan. The Japanese company remains committed to creating long term value for its shareholders and focuses on performance and producing consistent returns. The Ministry of Corporate Affairs (MCA) notified the IEPF (Uploading of Information Regarding Unpaid and Unclaimed Amounts Lying with Companies) Rules, 2012 (IEPF Rules), which is applicable to the corporation. Information and announcements about this can be found on the company's website. The company has revenues of over US$ 4.5 billion and completed the acquisition of Ranbaxy Laboratories Limited, an international pharmaceutical company, in 2015. | Health Technology |
- Stock Market
- Insiders
- Isao Muramatsu
